ALSTODT LANCE 4
4 · BioRestorative Therapies, Inc. · Filed Mar 22, 2023
Insider Transaction Report
Form 4
ALSTODT LANCE
DirectorPresident, CEO, COB
Transactions
- Tax Payment
Common Stock
2023-03-20$2.92/sh−6,729$19,649→ 180,218 total
Holdings
- 293,479
Stock Option
Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying) - 42,059
Stock Option
Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying) - 106,762
Stock Option
Exercise: $2.91Exp: 2033-02-17→ Common Stock (106,762 underlying)
Footnotes (5)
- [F1]Shares were withheld from vested stock grant to pay the associated withholding taxes.
- [F2]Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
- [F3]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
- [F4]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning on November 4, 2022 and continuing every three months thereafter until fully vested.
- [F5]The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.